Cargando…
AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
BACKGROUND: Bone metastasis is one of the most common complications in clinical intractable castration-resistant prostate cancer (CRPC) and advanced prostate cancer period. The invasion ability of cancer cells was thought to have important relationship with the potential of cancer metastasis. EP4 re...
Autores principales: | Xu, Song, Ge, Jing-Ping, Zhang, Zheng-Yu, Zhou, Wen-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565529/ http://dx.doi.org/10.21037/tau.2017.s065 |
Ejemplares similares
-
AB063. A prostaglandin E (PGE) receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP-PKA/PI3K-AKT signaling pathway
por: Xu, Song, et al.
Publicado: (2017) -
AB066. MiR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2017) -
AB065. Confocal laser endomicroscopy for diagnosing malignant bladder tumour: a pilot study
por: Zhang, Zhensheng, et al.
Publicado: (2018) -
AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer
por: Xu, Song, et al.
Publicado: (2017) -
AB091. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells
por: Wang, Yong, et al.
Publicado: (2017)